ReviewCureus2024

Safety and Efficacy of Remogliflozin in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Jay Tewari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.